Synthesis of FeCo/C NPs
7 nm FeCo/C NPs were prepared by dissolving Fe(NO 3 ) 3 ·9H 2 O (2.424 g, 6 mmol, Aldrich, 98%) and Co(NO 3 ) 2 ·6H 2 O (1.164 g, 4 mmol, Aldrich, 98%) in 30 mL of distilled water and then 2.9 mmol of sucrose (Aldrich, 99%) was added. The mixture was stirred vigorously to form a clear solution and then placed in a 45 mL capacity Teflon-lined stainless steel autoclave, which was heated in an oven to 190 o C for 9h. For 11 nm FeCo/C NPs, the mixture was heated to 220 o C for 9h. The products were washed several times with distilled water, filtered off and finally dried in a drying oven at 80 o C for 5h. Subsequently, the dried products were annealed at 1000 o C for 3h under Ar atmosphere to allow for the growth of the carbon graphite shell on the surface of FeCo NPs. To remove the remaining carbon graphite, the products were washed several times with distilled water and separated using a bar magnet.
The number of graphite shells was controlled by varying the amount of sucrose between 2.9 mmol and 8.8 mmol. To prepare large amounts of FeCo/C magnetic NPs in one step, 13.5744 g of Fe(NO 3 ) 3 ·9H 2 O (33.6 mmol) and 6.5184 g of Co(NO 3 ) 2 ·6H 2 O (22.4 mmol) were added to 30 mL of distilled water, which was followed by the addition of 14.5 mmol of sucrose under the above mentioned reaction conditions. The amount of the FeCo/C NPs was as much as 5 g with a yield greater than 95 %.
Synthesis of Fe 3 O 4 Nanoparticles
Synthesis of Iron-Oleate Complex: Monodisperse iron oxide (magnetite; Fe 3 O 4 ) nanoparticles (NPs), 11nm in diameter were synthesized according to previously reported protocol [12a] . Briefly, the iron-oleate complex was prepared by dissolving iron chloride (FeCl 3 .6H 2 O, 4 mmol, Aldrich, 98%) and sodium oleate (12mmol, TCI, 97%) in a mixture solvent composed of 8 ml ethanol, 6 ml distilled water and 14 ml hexane under inert atmosphere. The resulting solution was then heated to 70 °C and maintained at that was then cooled down to room temperature and the nanocrystals were then precipitated out using ethanol and centrifuged to yield monodisperse 11nm Fe 3 O 4 nanoparticles. The nanoparticles were then characterized using transmission electron microscopy.
Physical Characterization of the FeCo/C NPs
The NPs were characterized using XRD (Bruker D8 X-ray diffractometer with CuKα radiation (Ni filter)), TEM (Tecnai G2 and 
Synthesis of Functionalized Dextrans:
Dextran functionalized with 4-nitrophenyl chloroformate groups (4-NC dextran) (2)
Scheme 1 shows the synthesis of 4-NC dextran [25] . For a complete dissolution of dextran (1) in DMF, 15 g (92 mmol) dextran (from Leuconostoc spp, Aldrich, M r = 6,000) and 5.0 g (118 mmol, 2 w/v %) water-free lithium chloride (LiCl, Acros Organics, 98%) were suspended in 250 ml DMF and stirred at 90 °C until a clear solution appears. The reaction mixture was cooled to 0 °C, and pyridine (4.2 mL, 52 mmol, Alfa Aesar, 99%) was added to the dextran solution followed by 4-NC (10.5g, 52 mmol, Acros Organics, 97% 
Dextran functionalized with carboxyl groups (4)
Scheme 2shows the representative synthesis for obtainingdextran functionalized by carboxyl groups (4). Carboxydextran was synthesized using the methods reported previously [26] . 6 g dextran was dissolved in 20 mL 0.1 M NaOH. Then 1M bromoacetic acid (1.4 g, Aldrich, 98%) and 10 mL 2 M NaOH (0. Attachment of siRNA to the FeCo/C NPs: For the siRNA to silence EGFP/EGFRvIII gene in U87-EGFP /EGFRvIII cells, we utilized the layer-by-layer (LbL) method with slight modifications to the reported procedure (Reference). 1 ml of 1.0 mg/ml polyethyleneimine (PEI, MW 10,000) in distilled water was added to 0.5 -1.0 mg carboxydextran FeCo/C NPs.
After sonication for 2-4 hours under neutral pH, the coated particles were purified using ultracentrifugation and subsequent washing with distilled water. After characterization of the surface charge using zeta potential measurement (see Fig. S13 ), 10 l of 0.1mM siRNA solution in degassed PBS was added to 100 l of PEI coated FeCo/C solution (5 mg/ml).
After mild stirring for 1-2 hours, the NPs were purified by centrifugation and washing.
Following this, another layer of PEI was deposited on the siRNA layer of FeCo/C-PEI with the same concentration and reaction volume as first PEI layer by stirring mildly for 1-2 hours.
Sonication was avoided to protect the siRNA from heating and degradation. Final products was purified by ultracentrifugation (14,000 rpm) and washing with 1.0 mM NaCl solution.
Surface charge was characterized using zeta potential measurement (Zetasizer Nano ZS, Malvern Instruments, Westborough, MA) to perform the siRNA transfection experiment. FBS, 1% Streptomycin-penicillin and 1% Glutamax (Invitrogen, Carlsbad, CA) were used as basic components of growth media including Geneticin G418 (100 μg/ml, Invitrogen) as a selection marker for U87-EGFP and Hygromycin (100 μg/ml, Invitrogen) for U87-EGFRvIII.
Cell Culture of U87-EGFP, U87-EGFRvIII and other
Astrocytes were cultured in the above mentioned growth media without any selection markers, while PC-12 cells were cultured in DMEM with 10% horse serum, 5% FBS and 1%
Streptomycin-penicillin. All cells were cultured at 37 o C in humidified 5% CO 2 atmosphere. In presence of EGFR antibody the cells readily take up the FeCo/C NPs. However, the cell viability is intact in absence of magnetic field (b2) as compared to control. On hyperthermal treatment, the cell viability decreases significantly after 4 h.
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